# Preoperative Brimonidine on IOP of Patients Undergoing RALP

> **NCT02818816** · PHASE4 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 26 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** brimonidine tartrate 0.2%
- **OTHER:** Carboxymethylcellulose Eye Drops

## Key facts

- **NCT ID:** NCT02818816
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-29
- **Primary completion:** 2017-01-24
- **Final completion:** 2017-08-07
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2018-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02818816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02818816, "Preoperative Brimonidine on IOP of Patients Undergoing RALP". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02818816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*